Table 2.

Comparison of clinical indicators and HPV subtypes between SCC and AC

Clinical Indicators	SCC (n = 238)	AC (n = 81)	P
Age	50(43,56)	47(43,56)	0.509
Gravidity	3(2,4)	3(2,4)	0.813
Parity	1(1,2)	2(1,2)	0.092
BMI	22.89(21.08,24.93)	23.01(21.00,24.37)	0.456
RBC	4.08(3.88,4.38)	4.01(3.79,4.34)	0.205
WBC	5.47(4.56,6.58)	5.43(4.63,6.71)	0.706
PLT	209(173.00,241.57)	208(179.16,242.50)	0.959
SCCAg	1.5(0.9,2.9)	1(0.7,1.6)	< 0.001*
CA125	13.75(10.80,21.33)	17.50(11.55,24.85)	0.031*
CA19-9	10.8(7.08,16.80)	12.3(8.30,21.50)	0.030*
Neutrophil Percentage	58.1(53.00,63.50)	57.8(51.85,64.35)	0.913
Lymphocyte Percentage	31.45(27.10,36.43)	31(25.20,35.70)	0.349
CYFRA 21–1	2.4(1.78,3.40)	2.2(1.60,2.95)	0.023*
CEA	1.8(1.10,2.80)	1.9(1.30,3.85)	0.084
Menopausal Status			0.077
No	114(47.9%)	48(59.3%)
Yes	124(52.1%)	33(40.7%)
Smoking History			0.479
No	228(95.8%)	79(97.5%)
Yes	10(4.2%)	2(2.5%)
Clinical Symptoms			0.030*
Asymptomatic or Other	43(18.1%)	26(32.1%)
Contact Bleeding	129(54.2%)	37(45.7%)
Irregular Vaginal Bleeding	66(27.7%)	18(22.2%)
HPV Subtypes			< 0.001*
Low Risk	205(86.1%)	28(34.6%)
Medium Risk	13(5.5%)	3(3.7%)
High Risk	20(8.4%)	50(61.7%)

^*A p value of < 0.05 was considered to indicate significant difference